Crunching the numbers: trademark activity during COVID-19 Robert Reading, director of professional services and strategy at CompuMark (part of Clarivate), looks at COVID-19’s impact on pharmaceutical and medical trademark activity – and reveals some surprising findings By Robert Reading September 15 2020
